Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

1.

Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk.

Chen X, Weaver J, Bove BA, Vanderveer LA, Weil SC, Miron A, Daly MB, Godwin AK.

Hum Mol Genet. 2008 May 1;17(9):1336-48. doi: 10.1093/hmg/ddn022. Epub 2008 Jan 19.

PMID:
18204050
[PubMed - indexed for MEDLINE]
Free Article
2.

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K.

Clin Cancer Res. 2002 Dec;8(12):3776-81.

PMID:
12473589
[PubMed - indexed for MEDLINE]
Free Article
3.

High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.

Shahedi K, Emanuelsson M, Wiklund F, Gronberg H.

Cancer. 2006 Mar 15;106(6):1237-42.

PMID:
16475207
[PubMed - indexed for MEDLINE]
Free Article
4.

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Graeser MK, Engel C, Rhiem K, Gadzicki D, Bick U, Kast K, Froster UG, Schlehe B, Bechtold A, Arnold N, Preisler-Adams S, Nestle-Kraemling C, Zaino M, Loeffler M, Kiechle M, Meindl A, Varga D, Schmutzler RK.

J Clin Oncol. 2009 Dec 10;27(35):5887-92. doi: 10.1200/JCO.2008.19.9430. Epub 2009 Oct 26.

PMID:
19858402
[PubMed - indexed for MEDLINE]
Free Article
5.

Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families.

Eerola H, Heinonen M, Heikkilä P, Kilpivaara O, Tamminen A, Aittomäki K, Blomqvist C, Ristimäki A, Nevanlinna H.

Breast Cancer Res. 2008;10(1):R17. doi: 10.1186/bcr1863. Epub 2008 Feb 14.

PMID:
18275599
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Allele imbalance, or loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction mammoplasty tissues.

Larson PS, Schlechter BL, de las Morenas A, Garber JE, Cupples LA, Rosenberg CL.

J Clin Oncol. 2005 Dec 1;23(34):8613-9.

PMID:
16314623
[PubMed - indexed for MEDLINE]
Free Article
7.

Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer.

Machackova E, Foretova L, Lukesova M, Vasickova P, Navratilova M, Coene I, Pavlu H, Kosinova V, Kuklova J, Claes K.

BMC Cancer. 2008 May 20;8:140. doi: 10.1186/1471-2407-8-140.

PMID:
18489799
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.

Mote PA, Leary JA, Avery KA, Sandelin K, Chenevix-Trench G, Kirk JA, Clarke CL; kConFab Investigators.

Genes Chromosomes Cancer. 2004 Mar;39(3):236-48.

PMID:
14732925
[PubMed - indexed for MEDLINE]
9.

Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.

Birgisdottir V, Stefansson OA, Bodvarsdottir SK, Hilmarsdottir H, Jonasson JG, Eyfjord JE.

Breast Cancer Res. 2006;8(4):R38.

PMID:
16846527
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Allelic imbalance in BRCA1 and BRCA2 gene expression and familial ovarian cancer.

Shen J, Medico L, Zhao H.

Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):50-6. doi: 10.1158/1055-9965.EPI-10-0720. Epub 2010 Nov 30.

PMID:
21119070
[PubMed - indexed for MEDLINE]
Free Article
12.

[BRCA1 and BRCA2 gene mutations of familial breast cancer from Shanghai in China].

Song CG, Hu Z, Yuan WT, Di GH, Shen ZZ, Huang W, Shao ZM.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006 Feb;23(1):27-31. Chinese.

PMID:
16456781
[PubMed - indexed for MEDLINE]
13.

Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer.

Patmasiriwat P, Bhothisuwan K, Sinilnikova OM, Chopin S, Methakijvaroon S, Badzioch M, Padungsutt P, Vattanaviboon P, Vattanasapt V, Szabo C, Saunders GF, Goldgar D, Lenoir GM.

Hum Mutat. 2002 Sep;20(3):230.

PMID:
12203997
[PubMed - indexed for MEDLINE]
14.
15.

MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.

Yarden RI, Friedman E, Metsuyanim S, Olender T, Ben-Asher E, Papa MZ.

Breast Cancer Res Treat. 2008 Oct;111(3):497-504. Epub 2007 Nov 18.

PMID:
18026875
[PubMed - indexed for MEDLINE]
16.
17.

High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer.

Kristiansen M, Knudsen GP, Maguire P, Margolin S, Pedersen J, Lindblom A, Ørstavik KH.

J Med Genet. 2005 Nov;42(11):877-80. Epub 2005 May 6.

PMID:
15879497
[PubMed - indexed for MEDLINE]
Free PMC Article
18.
19.

Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families.

Guénard F, Labrie Y, Ouellette G, Joly Beauparlant C, Simard J, Durocher F; INHERIT BRCAs.

J Hum Genet. 2008;53(7):579-91. doi: 10.1007/s10038-008-0285-z. Epub 2008 Apr 15.

PMID:
18414782
[PubMed - indexed for MEDLINE]
20.

Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors.

Arnold JM, Choong DY, Thompson ER; kConFab, Waddell N, Lindeman GJ, Visvader JE, Campbell IG, Chenevix-Trench G.

Breast Cancer Res Treat. 2010 Jan;119(2):491-6. doi: 10.1007/s10549-008-0269-x. Epub 2009 Feb 3.

PMID:
19189213
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk